SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-008797
Filing Date
2024-01-31
Accepted
2024-01-31 16:11:43
Documents
1
Period of Report
2024-01-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244611-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm244611-3_4seq1.xml 4 24083
  Complete submission text file 0001104659-24-008797.txt   25562
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41929 | Film No.: 24583013

Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Issuer) CIK: 0001868279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)